Technologies

Therapeutics

• Novel Cancericidal Tubulin Ligands That Inhibit Microtubule Polymerizatin, Phosphorylate bcl-2 and Induce Apoptosis in Tumor Cells
• A Novel Baculovirus/Adenovirus Hybrid Vector For The Rescue, Production And Titration Of High-Capacity Adenovirus Amplicon Vectors
• The Use of a specific Non-Steroidal Anti-Inflammatory Drug  to Reduce Restenosis Following Arterial Revascularization Procedures
• HIV-1 Inhibitory Protein Purified from Transformed CD8 Cells
• Prolactin Regulatory Element Binding Protein and Uses Thereof
• Human Urate Transporter - A New Drug Discovery Target
• Vectors for Gene Therapy of Erythroid Disorders
• Prolactin Regulatory Element Binding Protein and Used Thereof. "PREB a WD40 Motif protein Expressed in Pituitary and Brain"
• Inhibition of Microtubule Assembly in Tumor Cells by 3-Bromoacetlyamino benzoylurea (3-BAABU) a New Cancericidal Compound
• Antifungal Compound Produced by Bacillus Bacteria
• Use of Famotidine and Related Compounds in the Treatment of Movement Disorders
• Cloning and Expression of Biologically Active Alpha-Galactosidase A as a Fusion Protein
• Methods and Compositions for the Treatment of Bone Resorbtion Disorders including Osteoporosis
• Methods and Compositions for the Reduction of Xenotransplantation Rejection
• Mutant Activated Gs and Adenylyl Cyclase 2 for Use as Therapeutic Agents
• Cloning and Expression of Pur Proteins
• Methods for identifying compounds that bind to PUR protein
• Method and composition for the treatment of apathy-amotivation syndrome.
• Identification and Analysis of a Novel Nucleic Acid Channel Protein from Kidney
• Recombinant Newcastle Disease Virus RNA Expression Systems and Vaccines
• Genetically Engineered Attenuated Negative Strand Viruses with Altered Interferon Antagonist Activity for Use as Vaccines
• A New Pituitary Factor that Differentiates Breast Carcinoma in Vitro
• Novel Prostaglandins for Glaucoma Therapy
• Use of a 1A-Adrenergic (Receptor) Antagonists in Glaucoma Therapy.
• Treatment of Autonomic Nerve Dysfunction with Botulinum Toxins.
• Administration of Ketamine to Ameliorate Treatment Resistant Depression
• Novel protein useful for coating stents for the effective treatment of intimal smooth muscle cell hyperplasia
• Genetically modified bacteria useful for the treatment of cancer
• Novel Embryonic Stem (ES) Cell Derived Cardiovascular Progenitors for Cellular Therapy and Drug Discovery

Diagnostics

• A Sensitive & Accurate Novel Method of Isothermal Nucleic Acid Amplification
• A Sensitive Assay System to Measure the Metastatic Potential of Human Tumors
• DNA-Based Steganographic Marking of Documents, Objects or Liquids
• A highly Sensitive Immunocytochemical method for diagnosis of malignant Effusions
• Monoclonal Antibody that Distinguishes Between Phosphorylated and Non-phosphorylated Histone H1, and Uses Thereof
• A Test for the Detection of Anti-Heparin Antibodies
• Non-Invasive Agents for Diagnosis and Prognosis of the Progression of Fibrosis.
• SSeCKS, A Novel Tumor Supressor
• Detection of Mammary Tumor Virus ENV Gene-Like Sequences in Human Breast Cancer.
• Annexin-V Resistance Tests/Lupus Procoagulant Assays.

Other

• A DNA Based Computer
• Procedure for Preparing Enriched Gene Expression Libraries
• A Novel Packaging Cell Line for the Rescue, Production and Titration of High-Capacity Adenovirus Amplicon Vectors
• Tomographic Pillow
• Laboratory Animals Carrying Null Mutations in Neurofilament Genes (Transgenic animal models for neurodegenerative disease)
• Immortalized, Homozygous Stat1-Deficient Cell Lines and Their Uses.
• Novel method for stable transfection of stem cells
• Identification and targeting of the ROSA26 locus in human embryonic stem cells